Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Campath-1H in Primary Renal Allograft Transplantation
NCT00365846Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Aug 2000
- Primary completion
- Jul 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of alemtuzumab in renal transplant rejection (RTR), sponsored by University of Wisconsin–Madison. Started Aug 2000; status: completed.
02
Drugs
alemtuzumab
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT00365846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365846.